Chairman’s message
Dear Colleagues, Dear Friends, Dear All,
In recent years, Gortec has experienced a strong dynamic in its therapeutic trials, some of which are unique, others innovative, and yet others strategic.
The biannual meetings of the Head&Neck intergroup provide opportunities to share progress and discuss new projects, with representation from professions involved in managing head and neck carcinomas.
Director's message
Dear colleagues, dear friends,
Clinical research is becoming increasingly complex with more constraints for investigators, stricter regulations, and exponentially growing costs for sponsors. In this context, it is essential to preserve and strengthen our academic research potential, particularly through cooperative oncology groups.
Trials Newsletters
Last Newsletters available online
Ongoing Clinical Trials
ADCC
Newsletter ADCC
TPFmORL
Newsletter TPFmORL
REWRITe
Newsletter REWRITe
NIVOPOST-OP
Newsletter NIVOPOST-OP
StereoPostOp
Newsletter StereoPostOp
SIMPA01
Newsletter SIMPA01
REACH
Newsletter REACH
SANTAL
Newsletter SANTAL
Pembrorad
Newsletter Pembrorad
OMET
Newsletter OMET
SALTORL
Newsletter SALTORL
Completed, pending publication
Elan
Newsletter Elan
Clinical Trials published
TPExtreme
Newsletter TPExtreme
Partnership Trials
OSKAR
Newsletter OSKAR